We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intermittent Dosing Of Selumetinib In Childhood NF1 Associated Tumours (INSPECT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03326388
Recruitment Status : Recruiting
First Posted : October 31, 2017
Last Update Posted : February 24, 2023
Sponsor:
Collaborator:
AstraZeneca
Information provided by (Responsible Party):
Great Ormond Street Hospital for Children NHS Foundation Trust

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 2023
Estimated Study Completion Date : December 2023
Publications: